SERUM THYMIDINE KINASE AND VASCULAR EN DOTHELIAL GROWTH FACTOR (VEGF) IN RENAL CELL CARCINOMA

被引：0
|
作者：
Nisman, B. [1 ]
Nechushtan, H. [1 ]
Yutkin, V. [2 ]
Peretz, T. [1 ]
Gronowitz, S. [3 ]
Pode, D. [2 ]
机构：
[1] Hadassah & Hebrew Univ, Med Ctr, Dept Oncol, Jerusalem, Israel
[2] Hadassah & Hebrew Univ, Med Ctr, Dept Urol, Jerusalem, Israel
[3] Uppsala Univ, Grp Clin Virol, Dept Med Sci, Uppsala, Sweden
来源：
TUMOR BIOLOGY | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [1] Serum level of vascular endothelial growth factor (VEGF) as an independent prognostic factor in metastatic renal cell carcinoma (MRCC)
    Negrier, S.
    Chabaud, S.
    Escudier, B.
    Ravaud, A.
    Chevreau, C.
    Blay, J. Y.
    Delva, R.
    Biota, C.
    Perol, D.
    Menetrier-Caux, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
    Zigeuner, RE
    Langner, C
    Rehak, P
    Auprich, M
    Lipsky, K
    Pummer, K
    Schips, L
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 98 - 98
  • [3] Expression of vascular endothelial growth factor (VEGF) and activated vascular endothelial growth factor receptors (VEGFR) in renal cell carcinoma
    Ha, Byeong Keun
    Park, Moonja Chung
    [J]. MODERN PATHOLOGY, 2006, 19 : 82 - 82
  • [4] Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
    Schips, Luigi
    Dalpiaz, Orietta
    Lipsky, Katja
    Langner, Cord
    Rehak, Peter
    Puerstner, Peter
    Pummer, Karl
    Zigeuner, Richard
    [J]. EUROPEAN UROLOGY, 2007, 51 (01) : 168 - 174
  • [5] Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma
    Ljungberg, B
    Jacobsen, J
    Häggström-Rudolfssson, S
    Rasmuson, T
    Lindh, G
    Grankvist, K
    [J]. UROLOGICAL RESEARCH, 2003, 31 (05): : 335 - 340
  • [6] Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma
    Börje Ljungberg
    Jan Jacobsen
    Stina Häggström-Rudolfssson
    Torgny Rasmuson
    Gudrun Lindh
    Kjell Grankvist
    [J]. Urological Research, 2003, 31 : 335 - 340
  • [7] Establishment of the classifier for a response to vascular endothelial growth factor (VEGF)-tyrosine kinase inhibitor (TKI) in metastatic renal cell carcinoma
    Go, Heounjeong
    Kang, Mun Jung
    Kim, Pil-Jong
    Park, Ja-Min
    Lee, Jae-Lyun
    Park, Ji Young
    Cho, Yong Mee
    [J]. CANCER RESEARCH, 2016, 76
  • [8] Expression analysis of the vascular endothelial growth factor (VEGF) family in renal cell carcinoma: Targeting the VEGF pathway
    Lam, JS
    Leppert, JT
    Yu, H
    Seligson, DB
    Dong, J
    Horvath, S
    Pantuck, AJ
    Figlin, RA
    Belldegrun, AS
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 122 - 122
  • [9] Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma : comparison with serum vascular endothelial growth factor
    Tanimoto, Shuji
    Fukumori, Tomoharu
    El-Moula, Gad
    Shiirevnyamba, Avirmed
    Kinouchi, Shinichiro
    Koizumi, Takahiro
    Nakanishi, Ryoichi
    Yamamoto, Yasuyo
    Taue, Ryuichi
    Yamaguchi, Kunihisa
    Nakatsuji, Hiroyoshi
    Kishimoto, Tomoteru
    Izaki, Hirofumi
    Oka, Natsuo
    Takahashi, Masayuki
    Kanayama, Hiro-Omi
    [J]. JOURNAL OF MEDICAL INVESTIGATION, 2008, 55 (1-2): : 106 - 111
  • [10] Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma
    Christoph W. M. Reuter
    Michael A. Morgan
    Viktor Grünwald
    Thomas R. W. Herrmann
    Martin Burchardt
    Arnold Ganser
    [J]. World Journal of Urology, 2007, 25 : 59 - 72
12345